logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Opioid Dependence Uncomplicated

    FiltersReset Filters
    5 results

    • buprenorphine

      (BUPRENORPHINE)
      Rhodes Pharmaceuticals L.P.
      Usage: Buprenorphine Sublingual Tablets are indicated for treating opioid dependence, particularly during induction. They should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine hydrochloride

      (buprenorphine hydrochloride)
      Advagen Pharma Ltd
      Usage: Buprenorphine Sublingual Tablets are indicated for treating opioid dependence, primarily during induction. They should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.

    • suboxone

      (buprenorphine hydrochloride, naloxone hydrochloride)
      INDIVIOR INC.
      Usage: SUBOXONE sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • vivitrol

      (naltrexone)
      Alkermes, Inc.
      Usage: VIVITROL is indicated for the treatment of alcohol dependence in patients able to abstain before starting therapy and for preventing relapse to opioid dependence following detoxification. It should be used as part of a comprehensive management program that includes psychosocial support.

    • zubsolv

      (buprenorphine hydrochloride and naloxone hydrochloride)
      Orexo US, Inc.
      Usage: ZUBSOLV is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.